SHANGHAI, May 22, 2024
/PRNewswire/ -- Qiming Venture Partners, a global-leading venture
capital firm, is pleased to announce the promotion of Alex Zhou to Managing Partner.
As a Qiming home-grown Managing Partner, Alex first joined the
firm in 2014 as a Vice President and has since emerged as one of
the most active investors in frontier technologies, especially in
the field of artificial intelligence. Alex will join
fellow Managing Partners Duane Kuang, Nisa Leung and William
Hu in managing Qiming's operations.
In the past few years, Alex has actively participated in or led
investments in many outstanding technology companies across the
artificial intelligence, robotics, semiconductors, new energy
vehicles, and software sectors. Notable among these include
Roborock, UBTech, Unisound, Biren Technology, ROX Motor,
VIEWTRIX Technology, Zhipu AI, Mech-Mind Robotics, Axera,
HyperStrong, DeepWay, etc.
"I am deeply grateful for the guidance and trust I received from
Qiming over the past 10 years." Alex said. "We are at the forefront
of a new wave of technological revolution. This era will
undoubtedly bring about many bold innovators who will shape the
future. Together with all the Managing Partners and colleagues at
Qiming, I am excited and fully committed to seize the
opportunities, embrace any potential challenges, explore new
possibilities and build a better Qiming."
Since its inception 18 years ago, Qiming has always committed to
upgrading its institutional capabilities and team development in
order to stay ahead in an ever-evolving technological and market
landscape. The success achieved in the fields of healthcare, mobile
internet and frontier technology is a testament to this strategic
approach. Alex's promotion to the most senior position in the firm
demonstrates Qiming's continued confidence in the future of
technology innovation.
About Qiming Venture Partners
Qiming Venture Partners was founded in 2006. Currently, Qiming
Venture Partners manages eleven US
Dollar funds and seven RMB
funds with $9.5 billion in capital
raised. Since our establishment, we have invested in outstanding
companies in the Technology and Consumer (T&C) and Healthcare
industries at the early and growth stages.
Since our debut, we have backed over 530 fast-growing and
innovative companies. Over 200 of our portfolio companies have
achieved exits through IPOs at the NYSE, NASDAQ, HKEX, Shanghai
Stock Exchange, or Shenzhen Stock Exchange, or through M&A or
other means. There are also over 70 portfolio companies that have
achieved unicorn or super unicorn status.
Many of our portfolio companies are today's most influential
firms in their respective sectors,
including Xiaomi, Meituan, Bilibili, Zhihu, Roborock, Gan & Lee
Pharmaceuticals, Tigermed, Zai Lab,
CanSino Biologics, Schrödinger, APT Medical, New Horizon Health,
Sanyou Medical, AmoyDx, Berry Genomics, SinocellTech, UBTech,
Yuanxin Technology, Caidya, Belief BioMed, WeRide, among many
others.
View original
content:https://www.prnewswire.com/news-releases/qiming-venture-partners-promotes-alex-zhou-to-managing-partner-302153196.html
SOURCE Qiming Venture Partners